Takeda’sZasocitinibLandmarkPhase3PlaquePsoriasisDataShowPromisetoDeliverClearSkininaOnce-DailyPill,CatalyzingaNewEraofTreatment
===2025/12/19 9:50:40===
and regions are driven by our purpose and are grounded in the values that have defined us for more than two centuries. For more information, visitwww.takeda.com.
Important Notice
For the purposes of this notice, “press release” means this document, any oral presentation, any question-and-answer session and any written or oral material discussed or distributed by Takeda Pharmaceutical Company Limited (“Takeda”) regarding this release. This press release (including any oral briefing and any question-and-answer in connection with it) is not intended to, and does not constitute, represent or form part of any offer, invitation or solicitation of any offer to purchase, otherwise acquire, subscribe for, exchange, sell or otherwise dispose of, any securities or the solicitation of any vote or approval in any jurisdiction. No shares or other securities are being offered to the public by means of this press release. No offering of securities shall be
=*=*=*=*=*=
当前为第9/20页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页